BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 17587406)

  • 1. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides.
    Duchardt F; Fotin-Mleczek M; Schwarz H; Fischer R; Brock R
    Traffic; 2007 Jul; 8(7):848-66. PubMed ID: 17587406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions.
    Vives E
    J Mol Recognit; 2003; 16(5):265-71. PubMed ID: 14523939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.
    Fotin-Mleczek M; Welte S; Mader O; Duchardt F; Fischer R; Hufnagel H; Scheurich P; Brock R
    J Cell Sci; 2005 Aug; 118(Pt 15):3339-51. PubMed ID: 16079278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
    Chugh A; Eudes F
    FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine-rich cell-penetrating peptides.
    Schmidt N; Mishra A; Lai GH; Wong GC
    FEBS Lett; 2010 May; 584(9):1806-13. PubMed ID: 19925791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic TAT peptide transduction domain enters cells by macropinocytosis.
    Kaplan IM; Wadia JS; Dowdy SF
    J Control Release; 2005 Jan; 102(1):247-53. PubMed ID: 15653149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
    Ziegler A; Nervi P; Dürrenberger M; Seelig J
    Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape.
    Foerg C; Ziegler U; Fernandez-Carneado J; Giralt E; Rennert R; Beck-Sickinger AG; Merkle HP
    Biochemistry; 2005 Jan; 44(1):72-81. PubMed ID: 15628847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clathrin, caveolae, and dynamin-independent endocytic pathway requiring free membrane cholesterol drives HIV-1 internalization and infection in polarized trophoblastic cells.
    Vidricaire G; Tremblay MJ
    J Mol Biol; 2007 May; 368(5):1267-83. PubMed ID: 17395200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic cell-penetrating peptides induce ceramide formation via acid sphingomyelinase: implications for uptake.
    Verdurmen WP; Thanos M; Ruttekolk IR; Gulbins E; Brock R
    J Control Release; 2010 Oct; 147(2):171-9. PubMed ID: 20620184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
    Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
    J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligoarginine vectors for intracellular delivery: design and cellular-uptake mechanisms.
    Futaki S
    Biopolymers; 2006; 84(3):241-9. PubMed ID: 16333858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the impact of valency on the routing of arginine-rich peptides into eukaryotic cells.
    Kawamura KS; Sung M; Bolewska-Pedyczak E; Gariépy J
    Biochemistry; 2006 Jan; 45(4):1116-27. PubMed ID: 16430208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmembrane delivery of the cell-penetrating peptide conjugated semiconductor quantum dots.
    Chen B; Liu Q; Zhang Y; Xu L; Fang X
    Langmuir; 2008 Oct; 24(20):11866-71. PubMed ID: 18823093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry.
    Daecke J; Fackler OT; Dittmar MT; Kräusslich HG
    J Virol; 2005 Feb; 79(3):1581-94. PubMed ID: 15650184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer.
    Wadia JS; Dowdy SF
    Adv Drug Deliv Rev; 2005 Feb; 57(4):579-96. PubMed ID: 15722165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of cell-penetrating peptide-mediated peptide delivery.
    Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
    Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct uptake routes of cell-penetrating peptide conjugates.
    Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
    Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-penetrating peptides are excluded from the mitochondrial matrix.
    Ross MF; Murphy MP
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):1072-4. PubMed ID: 15506968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane permeability commonly shared among arginine-rich peptides.
    Futaki S; Goto S; Sugiura Y
    J Mol Recognit; 2003; 16(5):260-4. PubMed ID: 14523938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.